DALLAS -- Do not expect impressive statistics from Chandler Parsons in the immediate future.
The Dallas Mavericks' $46-million small forward won’t play enough to produce the kind of numbers expected from a player cashing those paychecks for weeks to come. The priority for Parsons, as well as the Mavs, is to make sure that his return from hybrid microfracture surgery on his right knee isn’t rushed.
The hope -- and firm belief -- is that the patience will allow Parsons to perform up to high expectations for much of this season and years to come.